Evidence map›Paper›PMID 19594628›Full record

ReviewImmunological reviews2009

Beta-glucan recognition by the innate immune system.

Helen S Goodridge, Andrea J Wolf, David M Underhill

Abstract readReview
In one paragraph

Review in Immunological reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 280 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
280citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

280 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Bioactivity research inFrontiers in fungal biology · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Effect of aNutrients · 2019
    Trial
  6. Article
  7. Non-Proliferative Immune Restoration byJournal of microbiology and biotechnology · 2026
    Article
  8. Article
  9. Ameliorative effects ofThe journal of allergy and clinical immunology. Global · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Acetylation and accessibility ofCell surface (Amsterdam, Netherlands) · 2026
    Article
  18. Article
  19. Article
  20. Article

220 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Helen S GoodridgeImmunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Andrea J Wolf
David M Underhill

Funding

Non-Toll-like receptor innate immune signalingR01AI071116 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI UNDERHILL, DAVID M. · 2008 to 2023
$6.3M
NIAID NIH HHS R01 AI071116
6 · The paper itself

Abstract

Beta-glucans are recognized by the innate immune system. This recognition plays important roles in host defense and presents specific opportunities for clinical modulation of the host immune response. Neutrophils, macrophages, and dendritic cells among others express several receptors capable of recognizing beta-glucan in its various forms. This review explores what is currently known about beta-glucan recognition and how this recognition stimulates immune responses. Special emphasis is placed on Dectin-1, as we know the most about how this key beta-glucan receptor translates recognition into intracellular signaling, stimulates cellular responses, and participates in orchestrating the adaptive immune response.

Indexed as

Immunity, InnateAnimalsbeta-GlucansDectin-1FungiHumansImmunity, ActiveLectins, C-TypeMembrane ProteinsNerve Tissue ProteinsPhagocytosisReceptors, ImmunologicRespiratory BurstSignal TransductionTranscriptional Activationbeta-glucan receptorbeta-GlucansDectin-1Lectins, C-TypeMembrane ProteinsNerve Tissue ProteinsReceptors, Immunologic

Identifiers

PMID19594628
PMCPMC6618291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.